Tag
- Novartis Reports Strong Q3 2023 Financial Results, Driven by... 2023-10-25
- Novartis sells 5 products 2022-12-16
- The multinational pharmaceutical company plans to sell its b... 2022-11-18
- Novartis Sandoz Launches First Esbriet Generic in US 2022-05-16
- Novartis Suspends Production of Two Radioligand Drugs Due to... 2022-05-07
- The Most Expensive Drug in The World! Novartis' SMA Gene The... 2022-04-28
- Novartis Global Restructuring To Cut Thousands of Jobs 2022-04-28
- Novartis' Canakinumab in NSCLC Phase 3 Trial Fails Again 2022-04-20
- Novartis has the most new drugs approved, and Roche's new dr... 2021-08-31
- Top 10 most expensive drugs in the world: Novartis gene ther... 2021-04-01
Market Analysis
- Palm Oil Market in December Experiences Volatile Decline Dec-30,2025
- December Cyclohexane Market Operates Weakly, Lacking Momentum for Price Increases Dec-30,2025
- Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025 Dec-30,2025
- December’s Coking Coal Market Primarily Exhibits Weak Performance Dec-30,2025
- This week, the soda ash market in China has been operating weakly Dec-30,2025